Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candida antigen sensitization versus cryotherapy for wart lesions
IRCT2015012016955N5Phase 2Completed
- Sponsor
- Vice Chancellor for Research of Mashhad University of Medical Sciences
- Start
- Dec 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of candida albicans antigen in verruca, common wart and plantar wart (2 arms), sponsored by Vice Chancellor for Research of Mashhad University of Medical Sciences. Started Dec 2013; status: completed.
02
Drugs
candida albicans antigen
03
Conditions
verrucacommon wartplantar wart
Beyond the preview
Go deeper on IRCT2015012016955N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015012016955N5.